This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Sep;75(3):685-9.

doi: 10.1210/jcem.75.3.1517354.

Clinical review 37: Endocrine treatment of prostate cancer

R J Santen¹

Affiliations

PMID: 1517354
DOI: 10.1210/jcem.75.3.1517354

Review

Clinical review 37: Endocrine treatment of prostate cancer

R J Santen. J Clin Endocrinol Metab. 1992 Sep.

. 1992 Sep;75(3):685-9.

doi: 10.1210/jcem.75.3.1517354.

Author

R J Santen¹

Affiliation

¹ Department of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033.

PMID: 1517354
DOI: 10.1210/jcem.75.3.1517354

No abstract available

PubMed Disclaimer

Similar articles

[Hormonal therapy (medical orchiectomy) in prostatic carcinoma].
Studer UE, Münch D. Studer UE, et al. Schweiz Med Wochenschr. 1990 Jun 16;120(24):881-7. Schweiz Med Wochenschr. 1990. PMID: 2193381 Review. German.
[The potential hormonal therapy of prostatic carcinoma].
Studer UE, Altwein J, Bartsch G. Studer UE, et al. Urologe A. 1991 Sep;30(5):310-6. Urologe A. 1991. PMID: 1949440 Review. German.
Endocrine treatment of prostate cancer: standard treatment and new perspectives.
Boccardo F, Pace M. Boccardo F, et al. In Vivo. 1993 Sep-Oct;7(5):423-4. In Vivo. 1993. PMID: 8110985 Review.
Complete androgen blockade for the treatment of prostate cancer.
Labrie F, Dupont A, Belanger A. Labrie F, et al. Important Adv Oncol. 1985:193-217. Important Adv Oncol. 1985. PMID: 3916740 Review. No abstract available.
Advanced prostate cancer. Hormonal treatment.
de la Haba-Rodríguez J. de la Haba-Rodríguez J. Tunis Med. 2005 Dec;83 Suppl 12:71-3. Tunis Med. 2005. PMID: 16430072 No abstract available.

See all similar articles

Cited by

Gonadotrophin-releasing hormone agonists. A guide to use and selection.
Filicori M. Filicori M. Drugs. 1994 Jul;48(1):41-58. doi: 10.2165/00003495-199448010-00005. Drugs. 1994. PMID: 7525194 Review.
Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone.
Chhipa RR, Lee KS, Onate S, Wu Y, Ip C. Chhipa RR, et al. Mol Cancer Res. 2009 Sep;7(9):1543-52. doi: 10.1158/1541-7786.MCR-08-0546. Epub 2009 Sep 8. Mol Cancer Res. 2009. PMID: 19737972 Free PMC article.
Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.
Rodriguez-Gonzalez A, Cyrus K, Salcius M, Kim K, Crews CM, Deshaies RJ, Sakamoto KM. Rodriguez-Gonzalez A, et al. Oncogene. 2008 Dec 4;27(57):7201-11. doi: 10.1038/onc.2008.320. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794799 Free PMC article.
Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.
Olokpa E, Moss PE, Stewart LV. Olokpa E, et al. PPAR Res. 2017;2017:9456020. doi: 10.1155/2017/9456020. Epub 2017 Oct 18. PPAR Res. 2017. PMID: 29181019 Free PMC article. Review.
Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer.
Srivastava TP, Ajmeriya S, Goel I, Talukdar J, Srivastava A, Parshad R, Deo SVS, Mathur SR, Gogia A, Rai A, Dhar R, Karmakar S. Srivastava TP, et al. BMC Cancer. 2024 Nov 13;24(1):1398. doi: 10.1186/s12885-024-13165-x. BMC Cancer. 2024. PMID: 39538154 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information